-
Abstract Number: 2131
Role of LECT2 in the Regulation of Bone Metabolism In Vitro and In Vivo
-
Abstract Number: 2132
A Quality Improvement Initiative to Increase Osteoporosis Screening in Internal Medicine Resident Led Primary Care Clinics
-
Abstract Number: 2133
Unveiling the Association Between Low-Density Lipoprotein Cholesterol Lowering and Fracture Risk Among Patients with Hyperlipidaemia in a Population-Based Cohort Study: The Lower, the Better
-
Abstract Number: 2134
PEX5 Acts as a Negative Regulator of RANKL-induced Osteoclastogenesis In Vitro and Inflammatory Calvarial Bone Destruction In Vivo
-
Abstract Number: 2135
Disability, Functional Limitation, and Use of Anti-fracture Drug Therapies in a Cohort of 3651 U.S. Adults with Osteogenesis Imperfecta
-
Abstract Number: 2136
Distal Radius Correlation with Femur and Lumbar Spine T-scores: A Comprehensive Analysis
-
Abstract Number: 2137
Fractures Post Lung Transplant: A Retrospective Cohort Study Conducted at an International Transplant Center
-
Abstract Number: 2138
DXA-derived 3D Parameters of the Hip Discriminate Prevalent Fragility Fractures in Individuals with Axial Spondyloarthritis
-
Abstract Number: 2139
Generation of a Human 3D Bone Model to Mimic Glucocorticoid- induced Osteoporosis In Vitro
-
Abstract Number: 2140
Frailty Is Associated with Lower Bone Mineral Density in US Veterans with Rheumatoid Arthritis
-
Abstract Number: 2141
Glucocorticoid Therapy-Associated Bone Fractures Are Associated with Osteoporosis Underscreening in Patients with Rheumatoid Arthritis
-
Abstract Number: 2142
Comparison of Bone Mineral Density at the Distal Radius, Hip, and Lumbar Spine in Female Patients Undergoing Surgery for Proximal Femur or Distal Radius Fractures: Implications for Osteoporosis Diagnosis
-
Abstract Number: 2143
Analysis of Effectiveness and Safety of Romosozumab in Patients with Very High Risk of Fracture in a Spanish Population
-
Abstract Number: 2144
Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis: Results from a Randomized Controlled Phase 3 Study to Compare CT-P41 (Proposed Denosumab Biosimilar) and Reference Denosumab
-
Abstract Number: 2145
Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta.
- « Previous Page
- 1
- …
- 142
- 143
- 144
- 145
- 146
- …
- 181
- Next Page »